Business Segments Evotec SE CBOE

Stocks

Market Closed - CBOE 01:30:00 20/08/26 am AEST			After hours 05:15:28 am
3.724 ^EUR	0.00%		3.399	-8.73%

13/08	Energiekontor hits March low, doubts over a strong second half	DP
13/08	Evotec's final first-half results once again spook investors	DP

Breakdown by Business Segment (EUR)

Fiscal Period: December	2021	2022	2023	2024	2025
Life Sciences Tools and Services
Discovery and Preclinical Development	-	-	-	612M	529M
Gross Profit	-	-	-	102M	46.81M
EBITDA	-	-	-	12.7M	-12.04M
D&A	-	-	-	77.24M	74.77M
Operating Income	-	-	-	-126M	-74.48M
Just - Evotec Biologics	-	-	-	187M	260M
Gross Profit	-	-	-	13.55M	67.43M
EBITDA	-	-	-	9.87M	53.18M
D&A	-	-	-	24.4M	24.71M
Operating Income	-	-	-	-16.35M	18.26M
EVT Innovate	147M	205M	267M	-	-
Gross Profit	-	-	-	-	-
EBITDA	-17.52M	-6.6M	958K	-	-
D&A	3.99M	5.09M	5.45M	-	-
Operating Income	-22.11M	-11.67M	-4.49M	-	-
EVT Execute	610M	736M	739M	-	-
Gross Profit	-	-	-	-	-
EBITDA	125M	108M	65.39M	-	-
D&A	63.62M	76.57M	87.53M	-	-
Operating Income	63.11M	32.52M	-43.02M	-	-
Transition	-	-	-	-	-
Intersegment Elimination	-139M	-189M	-224M	-1.21M	-496K
Gross Profit	-	-	-	-865K	-17K
Operating Income	-	-	-	-	-

Geographical breakdown of sales (EUR)

Fiscal Period: December	2021	2022	2023	2024	2025
USA	-	-	459M	446M	432M
Total Assets	-	-	221M	258M	216M
Switzerland	-	-	64.92M	109M	162M
Total Assets	-	-	-	-	-
Total Assets	-	-	2.63M	-	-
Total Assets	-	-	-	-	-
Total Assets	-	-	-	-	-
Rest of the World	-	-	95.15M	82.28M	77.08M
United Kingdom	-	-	86.37M	92.52M	61.72M
Total Assets	-	-	221M	209M	181M
Germany	-	-	34.13M	32.9M	25.29M
Total Assets	-	-	153M	155M	188M
France	-	-	32M	19.91M	19.86M
Total Assets	-	-	338M	326M	89.7M
Total Assets	-	-	260M	240M	230M
Unallocated	-	-	-	14.45M	11.29M
Europe	-	-	-	-	-